Module 1

7:50am             Welcome and housekeeping remarks

Ayesha Hasan, MD and Raphael Pollock, MD, PhD

8:00                      Managing Acute Coronary Syndromes in Cancer Patients

Richard Gumina, MD, PhD

8:15                      Device Therapy in Cancer Patients

Mohammad Afzal, MBBS

8:30                     Managing Advanced Heart Failure in Cancer Patients

Richard Cheng, MD

8:45                      Ibrutinib-induced Cardiac Arrhythmias

Seema Bhat, MD

9:00                      Emerging and Potential Roles of Genetics within Cardio-Oncology

Ray Hershberger. MD

9:15                      Optimal uses of STRAIN Imaging in Patients with Cancer

Michael Wesley Milks, MD

9:30                      Big Data to Inform Modern Cardio-Oncology

Avirup Guha, MD, RPVI

9:45                      Identifying and Managing Radiation Induced CVD

Eric Miller, MD, PhD

10:00                    BREAK

 

Module 2

10:10am              Cardiovascular Toxicities of Immune Checkpoint Inhibitors

Ajay Vallakati, MBBS

10:25                    Emerging Directions in Tyrosine Kinase Inhibitor Cardiac Toxicity

Sakima Smith, MD, MPH

10:40                    Managing Valvular Heart Disease in the Cancer Patient

Scott Lilly, MD, PhD

10:55                    Impending Optimal Preventive Strategies in the Cardio-Oncology Clinic

                                   Tochukwu M. Okwuosa, DO

11:10                    Use of Advanced Cardiac Imaging in the Cancer Patient

Daniel Addison, MD

11:25                    Role CH/CHIP in Cardiovascular Disease

                                    Uma Borate, MBBS

11:40                    Managing Hypertension after Cancer Therapy Initiation

Jason Prosek, MD

11:55                    Cardio-Oncology Needs from the Perspective of an Oncologist

Bhuvaneswari Ramaswamy, MD, MRCP

12:10                   Cardiotoxicity after Cellular (CAR-T Cell) Therapies

Jonathan Brammer, MD

 

Module 3

Breakout Sessions:

12:55pm             Welcome and housekeeping

Dr. Addison

Breakout A:          Cancer Immune Checkpoint Inhibitor Associated Cardiotoxicities

Margaret Gatti-Mays, MD, MPH; Timothy Gauntner, DO, PhD; Avirup Guha, MD, RPVI; Tochukwu M. Okwousa, DO; and Ajay Vallakati, MBBS

1:00                      Case Scenario (immune Checkpoint Myocarditis)
                                   Timothy Gauntner, DO, PhD

1:05                      Case Scenario (CAR-T cell induced arrhythmias and heart failure)

                                   Timothy Gauntner, DO, PhD

1:10                      Panel Discussion of Cases

Margaret Gatti-Mays, MD; Timothy Gauntner, DO, PhD; Avirup Guha, MD, RPVI; Tochukwu M. Okwousa, DO; and Ajay Vallakati, MBBS

1:30                      Keynote Lecture: Immunotherapy-associated Cardiotoxicity -Where are We Going

Javid Moslehi, MD

 

Breakout B:          Novel Cancer Targeted and Immune Therapy associated Cardiotoxicities

Daniel Addison, MD; Jonathan Brammer, MD; Zachary Braunstein, MD; Richard Cheng, MD and Mahmoud Houmsse, MD

1:55                      Case Scenarios (Ibrutinib associated Atrial Fibrillation)
                                   Zachary Braunstein, MD

2:00                      Case Scenarios (Stem cell transplant associated CHF)
                                   Zachary Braunstein, MD

2:05                      Panel Discussion:

                                    Daniel Addison, MD; Jonathan Brammer, MD; Zachary Braunstein, MD;
                                    Richard Cheng, MD and Mahmoud Houmsse, MD

2:25                      Cardiac Medication Management Among Patients Receiving BTK Inhibitors

                                    Jordan Lundberg, PharmD, BCOP

 

2:50pm BREAK

 

Breakout C:          Cardiac Amyloidosis in the 21^st Century

Naresh Bumma, MD; Courtney Campbell, MD, PhD; Sharmila Dorbala, MD, MPH; Katarzyna Mikrut, MD; and Ajay Vallakti, MBBS

3:05                      Case Scenarios (Indeterminate PYP Imaging, and course of care)

                                   Katarzyna Mikrut, MD

3:10                      Case Scenarios (CHF in Myeloma, and Orthopedic associations)

                                   Katarzyna Mikrut, MD

3:15                      Panel Discussion:

                                      Naresh Bumma, MD; Courtney Campbell, MD, PhD; Sharmila Dorbala, MD, MPH; Katarzyna Mikrut, MD; and Ajay Vallakti,                                              MBBS

3:35                      Keynote: Modern Directions in Cardiac Amyloidosis

Sharmila Dorbala, MD, MPH

 

4:00       Meeting Adjournment – Daniel Addison, MD